Effects of gold nanoparticles on endotoxin-induced uveitis in rats

Investigative Ophthalmology and Visual Science

Volumn 53, Issue 13, 2012, Pages 8036-8041

  Pereira, David Valter ^a   Petronilho, Fabricia ^b   Pereira, Hilda Regina Silveira Benevides ^a   Vuolo, Francieli ^a   Mina, Francieli ^a   Possato, Jonathan Correa ^a   Vitto, Marcelo Fontana ^a   de Souza, Daniela Roxo ^a   da Silva, Luciano ^a   Paula, Marcos Marques da Silva ^a   de Souza, Claudio Teodoro ^a   Dal Pizzol, Felipe ^a  

^a UNIVERSIDADE DO EXTREMO SUL CATARINENSE   (Brazil)

^b UNIVERSITY OF SOUTHERN SANTA CATARINA   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTOXIN; GOLD NANOPARTICLE; GOLD SALT; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MYELOPEROXIDASE; PREDNISOLONE ACETATE; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AQUEOUS HUMOR; ARTICLE; INFLAMMATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REPEATED DRUG DOSE; UVEITIS; WESTERN BLOTTING;

ADMINISTRATION, TOPICAL; ANIMALS; AQUEOUS HUMOR; BLOTTING, WESTERN; DISEASE MODELS, ANIMAL; ENDOTOXINS; ENZYME-LINKED IMMUNOSORBENT ASSAY; GOLD COMPOUNDS; IRIS; LIPOPOLYSACCHARIDES; MALE; NANOPARTICLES; NF-KAPPA B; OXIDATIVE STRESS; PEROXIDASE; PREDNISOLONE; RATS; RATS, WISTAR; TOLL-LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR-ALPHA; UVEITIS, ANTERIOR;

EID: 84873357869     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.12-10743     Document Type: Article

References (44)

1. Dick AD. Immune mechanisms of uveitis: insights into disease pathogenesis and treatment. IntOphthalmolClin. 2000;40:1-18.
2. Durrani OM, Tehrani NN, Marr JE, Moradi P, Stavrou P, Murray PI. Degree, duration, and causes of visual loss in uveitis. Br J Ophthalmol. 2004;88:1159-1162.
3. Durrani OM, Meads CA, Murray PI. Uveitis: a potentially blinding disease. Ophthalmologica. 2004;218:223-236.
4. London NJ, Rathinam SR, Cunningham ET Jr. The epidemiology of uveitis in developing countries. Int Ophthalmol Clin. 2010;50:1-17.
5. Izumi-Nagai K, Nagai N, Ozawa Y, et al. Interleukin-6 receptormediated activation of signal transducer and activator of transcription-3 (STAT3) promotes choroidal neovascularization. Am J Pathol. 2007;170:2149-2158.
6. Kurihara T, Ozawa Y, Shinoda K, et al. Neuroprotective effects of angiotensin II type 1 receptor (AT1R) blocker, telmisartan, via modulating AT1R and AT2R signaling in retinal inflammation. Invest Ophthalmol Vis Sci. 2006;47:5545-5552.
7. Nagai N, Izumi-Nagai K, Oike Y, et al. Suppression of diabetesinduced retinal inflammation by blocking the angiotensin II type 1 receptor or its downstream nuclear factorkappaB pathway. Invest Ophthalmol Vis Sci. 2007;48:4342-4350.
8. Becker MD, Garman K, Whitcup SM, et al. Inhibition of leukocyte sticking and infiltration, but not rolling, by antibodies to ICAM-1 and LFA-1 in murine endotoxin-induced uveitis. Invest Ophthalmol Vis Sci. 2001;42:2563-2566.
9. Noda K, Miyahara S, Nakazawa T, et al. Inhibition of vascular adhesion protein-1 suppresses endotoxin-induced uveitis. FASEB J. 2008;22:1094-1103.
10. Hollyfield JG, Bonilha VL, Rayborn ME, et al. Oxidative damage-induced inflammation initiates age-related macular degeneration. Nat Med. 2008;14:194-198.
11. Sellak H, Franzini E, Hakim J, et al. Reactive oxygen species rapidly increase endothelial ICAM-1 ability to bind neutrophils without detectable upregulation. Blood. 1994;83:2669-2677.
12. Rosenbaum JT, McDevitt HO, Guss RB, et al. Endotoxininduced uveitis in rats as a model for human disease. Nature. 1980;286:611-613.
13. Satici A, Guzey M, Gurler B, et al. Malondialdehyde and antioxidant enzyme levels in the aqueous humor of rabbits in endotoxin-induced uveitis. Eur J Ophthalmol. 2003;13:779-783.
14. Daniel MC, Astruc D. Gold nanoparticles: assembly, supramolecular chemistry, quantum-size-related properties, and applications toward biology, catalysis, and nanotechnology. Chem Rev. 2004;104:293-346.
15. Yoshida S-I, Kato T, Sakurada S, et al. Inhibition of IL-6 and IL-8 induction from cultured rheumatoid synovial fibroblasts by treatment with aurothioglucose. Int Immunol. 1999;11:151-158.
16. Zhang CX, Lippard SJ. New metal complexes as potential therapeutics. Curr Opin Chem Biol. 2003;7:481-489.
17. Eisler R. Chrysotherapy: a synoptic review. Inflamm Res. 2003;52:487-501.
18. Navarro M, Fraile G, Velásquez M, et al. Effect of a goldchloroquine complex on inflammation-related leukocyte functions and cell viability. Comparison with auranofin. Arzneimittelforschung. 2006;56:826-833.
19. Han S, Kim K, Kim H, et al. Auranofin inhibits overproduction of pro-inflammatory cytokines, cyclooxygenase expression and PGE2 production in macrophages. Arch Pharm Res. 2008; 31:67-74.
20. Turkevich J, Stevenson PC, Hillier J. A study of the nucleation and growth processes in the synthesis of colloidal gold. Discuss Faraday Soc. 1951;11:55-75.
21. Aromal SA, Green DP. Synthesis of gold nanoparticles using Trigonella foenum-graecum and its size-dependent catalytic activity. Spectrochim Acta Mol Biomol Spectrosc. 2012;97:1-5.
22. Pereira DV, Steckert AV, Mina F, et al. Effects of an antagonist of the gastrin-releasing peptide receptor in an animal model of uveitis. Invest Ophthalmol Vis Sci. 2009;50:5300-5303.
23. De Young LM, Kheifets JB, Ballaron SJ, et al. Edema and cell infiltration in the phorbol ester-treated mouse ear are temporally separate and can be differentially modulated by pharmacologic agents. Agents Actions. 1989;26:335-341.
24. Draper HH, HadleyM. Malondialdehyde determination asíndex of lipid peroxidation. Methods Enzymol. 1990;186:421-431.
25. Levine RL, Garland D, Oliver CN, Amici A, Climent I, Lenz AG. Determination of carbonyl content in oxidatively modified proteins. Methods Enzymol. 1990;186:464-478.
26. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976;72:248-254.
27. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970; 227:680-685.
28. De Souza CT, Gasparetti AL, Pereira-da-Silva M, et al. Peroxisome proliferator-activated receptor gamma coactivator-1-dependent uncoupling protein-2 expression in pancreatic islets of rats: a novel pathway for neural control of insulin secretion. Diabetologia. 2003;46:1522-1531.
29. Toderas F, Iosin M, Astilean S. Luminescence properties of gold nanorods. Nucl Instrum Methods Phys Res B. 2009;267:400-402.
30. Noda K, Miyahara S, Nakazawa T, et al. Inhibition of vascular adhesion protein-1 suppresses endotoxin-induced uveitis. FASEB J. 2008;22:1094-1103.
31. Wang J, Lu H, Xu Y, et al. The effect of toll-like receptor 4 in the aqueous humor of endotoxin-induced uveitis. Int J Mol Sci. 2012;13:2110-2118.
32. Chen W, Hu X, Zhao L, et al. Expression of toll-like receptor 4 in uvea-resident tissue macrophages during endotoxin-induced uveitis. Mol Vis. 2009;15:619-628.
33. Li S, Lu H, Hu X, et al. Expression of TLR4-MyD88 and NF-jB in the iris during endotoxin-induced uveitis. Mediators Inflamm. 2010;2010:748218.
34. Ma JS, Kim WJ, Kim JJ. Gold nanoparticles attenuate LPSinduced NO production through the inhibition of NF-kappaB and IFN-beta/STAT1 pathways in RAW264.7 cells. Nitric Oxide. 2010;23:214-219.
35. Pérez-Guijo V, Santos-Lacomba M, Sanchez-Hernandez M. Tumor necrosis factor-alpha levels in aqueous humor and serum from patients with uveitis: the involvement of HLAB27. Curr Med Res Opin. 2004;20:155-157.
36. Santos Lacomba M, Marcos-Martin C, Gallardo-Galera JM. Aqueous humor and serum tumor necrosis factor-alpha in clinical uveitis. Ophthalmic. Res. 2001;33:251-255.
37. Curnow SJ, Wloka K, Faint JM, et al. Topical glucocorticoid therapy directly induces up-regulation of functional CXCR4 on primed T lymphocytes in the aqueous humor of patients with uveitis. J Immunol. 2004;172:7154-7161.
38. Koizumi K, Poulaki V, Doehmen S, et al. Contribution of TNFalpha to leukocyte adhesion, vascular leakage, and apoptotic cell death in endotoxin-induced uveitis in vivo. Invest Ophthalmol Vis Sci. 2003;44:2184-2191.
39. Caso JR, Lizasoain I, Lorenzo P, et al. The role of tumor necrosis factor-alpha in stress-induced worsening of cerebral ischemia in rats. Neuroscience. 2006;142:59-69.
40. Guggilam A, Haque M, Kerut EK, et al. TNF-alpha blockade decreases oxidative stress in the paraventricular nucleus and attenuates sympathoexcitation in heart failure rats. Am J Physiol Heart Circ Physiol. 2007;293:599-609.
41. Kim JH, Kim JH, Kim KW, Kim MH, Yu YS. Intravenously administered gold nanoparticles pass through the blood-retinal barrier depending on the particle size, and induce no retinal toxicity. Nanotechnology. 2009;20:505101.
42. Bakri SJ, Pulido JS, Mukherjee P, Marler RJ, Mukhopadhyay D. Absence of histologic retinal toxicity of intravitreal nanogold in a rabbit model. Retina. 2008;28:147-149.
43. Khlebtsov N, Dykman L. Biodistribution and toxicity of engineered gold nanoparticles: a review of in vitro and in vivo studies. Chem Soc Rev. 2011;40:1647-1671.
44. Sharma A, Tandon A, Tovey JC, et al. Polyethylenimineconjugated gold nanoparticles: gene transfer potential and low toxicity in the cornea. Nanomedicine. 2011;7:505-513.